Basic Materials
Gujarat Narmada Valley Fertilizers and Chemicals Limited (GNFC) breaks out, gains 5% intraday
Gujarat Narmada Valley Fertilizers and Chemicals Limited (GNFC) stock price is up 5% intraday at ₹537.2, breaking out in a fresh intraday computation. .
Gujarat Narmada Valley Fertilizers and Chemicals Limited (GNFC) gained +5% to ₹537.2 on the NSE on 16 Jun 2026. The stock is approaching a key resistance level at ₹540, just 0.4% away, after breaking out from its 6-month trendline. GNFC, a key player in the basic materials sector, specifically in chemicals, has shown a notable technical move today. This upward trend is somewhat isolated, as it does not align with broader sector momentum, indicating a company-specific catalyst rather than sector-wide influences.
Technical setup — trendlines & DMA
The current trendline structure for GNFC shows a 6-month support floor at ₹511.7, which is 4.75% below today’s price. The resistance level is at ₹539.54, just 0.44% above the current price. The 50-day moving average (DMA) at ₹484.9 is above the 200-DMA at ₹477.8, indicating a bullish trend. The stock is trading above both moving averages, suggesting a strong position. In terms of its 52-week range, GNFC is in the upper third, trading at 82% up from the 52-week low and 6.4% below the 52-week high, implying that a significant portion of the potential upside may already be priced in.
Snapshot: ₹537.20 on 2026-06-16 (chart frozen at publication)
Fundamentals & business context
With a PE ratio of 9.3 and profit margins at 10.4%, GNFC’s valuation appears reasonable given its current earnings. However, the revenue CAGR of -8.7% and profit CAGR of -18.1% over the past five years suggest a challenging growth environment. The 16.9% institutional ownership indicates that while some institutional investors see value, the majority are cautious. There was no NSE catalyst today, so the move is purely technical.
Algorithmic scorecard
The overall scorecard reflects a technically strong but fundamentally weak position. The strongest signals include the bullish sentiment over the last 30 days, with a 2.32x higher average volume on up days compared to down days, indicating systematic accumulation. Additionally, the stock’s low volatility, with a beta of 0.20, suggests it is a stable investment with less market risk. On the weaker side, the revenue CAGR of -8.7% and profit CAGR of -18.1% highlight the company’s declining growth trajectory. The inconsistent price growth, with mixed momentum over different timeframes, also poses a risk for investors.
Company outlook
Management outlined several key initiatives for the future. They expect capex benefits from the coal-based CCPP to accrue from H2 of FY27. The planned capex for FY27 is around INR 2,800 crores. Additionally, the company is exploring licensing for additional capacity with INEOS. These strategic moves aim to enhance operational efficiency and expand capacity, though the immediate impact on revenue and profit margins remains to be seen.
Get all details on GNFC — P&L, peers, shareholding and more on TradeAlone.
Basic Materials
Privi Speciality Chemicals Limited (priviscl) Q2 FY27: Prosperity with Orderliness
Privi Speciality Chemicals Limited (PRIVISCL) reports strong Q2 FY27 results with 13.9% revenue growth, 16.7% EBITDA, and 24.6% net profit.
Privi Speciality Chemicals Limited (PRIVISCL) has reported robust Q2 FY27 results, showcasing a strong financial performance under the theme of ‘Prosperity With Orderliness’. The company delivered Rs 773.16 Cr of total income, marking a 13.90% year-on-year growth. EBITDA surged by 16.66% to Rs 212.49 Cr, while net profit rose by 24.61% to Rs 117.03 Cr. These impressive figures reflect the resilience of Privi’s business model and disciplined execution.
Financial Highlights
The company’s strategic vision and disciplined execution have led to significant financial improvements. EBITDA margin improved by 65 basis points to 27.48%, and the return on capital employed (ROCE) increased by 216 basis points to 24.30%. The return on equity (ROE) also saw a substantial improvement of 134 basis points to 26.34%. Moreover, the net debt to EBITDA ratio improved by 37.9% to 0.51, and the net debt to equity ratio decreased by 32.1% to 1.07.
Growth Strategy
Privi Speciality Chemicals Limited remains well-positioned for future growth. The company’s diversified geographic presence has supported stability across markets, and the expansion projects are progressing as planned. New products are expected to expand the addressable market and contribute meaningfully to growth in the coming years. With a strong balance sheet, healthy cash flows, and a clear strategic roadmap, Privi Speciality Chemicals Limited is poised for continued prosperity.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Privi Speciality Chemicals Limited
Privi Speciality Chemicals Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.
Privi posts a 6.3% three-month gain, but softens in the last few weeks. The PEG of 0.30 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. The business compounds revenue at 16.6% and profits at 145.2% CAGR. That is strong double-digit growth on both counts. The stock gives back 2.7% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Both the business and the stock move in the right direction. Revenue grows at 16.6%, profits at 145.2%, and the PEG sits at 0.30 — below its growth rate. That combination is rare. Check Fundamentals of Privi Speciality Chemicals Limited.
Agricultural Inputs
Pi Industries Limited Unveils Pioxaniliprole, India’s First Indigenously Discovered Insecticide
PI Industries Limited (PIIND) unveils Pioxaniliprole, India’s first indigenously discovered insecticide, marking a significant milestone in agricultural inno.
PI Industries Limited (PIIND) has made a groundbreaking announcement today, unveiling Pioxaniliprole, India’s first indigenously discovered insecticide. This decade-long research breakthrough marks a defining milestone in India’s ability to originate world-class agricultural science and proprietary innovation.
A Milestone in Agricultural Innovation
Developed through more than a decade of original research, Pioxaniliprole demonstrates the country’s growing capability to originate novel scientific discoveries and create proprietary intellectual property. This achievement strengthens PI’s ambition to build a global, innovation-led Life Sciences company, creating original science and intellectual property from India for the world.
Significance Beyond a Single Molecule
The significance of Pioxaniliprole extends beyond a single molecule. It is the first outcome of a broader innovation pipeline at PI, spanning chemistry, biology, and biochemical solutions. Together, these mark an important step in India’s journey towards greater scientific self-reliance, strengthening indigenous research capabilities and creating opportunities for Indian-origin agricultural innovation to address challenges of global relevance.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of PI Industries Limited
PI Industries Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.
PI drops 16.5% over three months and trades near its 52-week lows. The PEG stands at 11.88 — severely stretched. Any earnings miss could trigger a sharp de-rating. Revenue grows at 1.1% CAGR. The company generates cash but does not compound aggressively. The stock sits at 5% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 1.1% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of PI Industries Limited.
Basic Materials
Kotyark Industries Limited (kotyark) Q2 FY27: PAT Surges 148% Yoy to ₹6.24 Crore; Ebitda Margin Expands to 20.72%
Kotyark Industries Limited (NSE: KOTYARK) announced Q2 FY27 results with a 148% YoY surge in PAT to ₹6.24 Crore, and a 20.72% EBITDA margin.
Kotyark Industries Limited (NSE: KOTYARK), a biodiesel manufacturing company, announced its unaudited financial results for the quarter and half year ended September 30, 2026 (Q2 & H1 FY27), as approved by the Board of Directors at its meeting held on October 28, 2026. This release discusses consolidated performance. In Q2 FY27, consolidated revenue from operations was ₹61.27 Crore, 5.5% lower than Q2 FY26, while EBITDA rose 50.7% to ₹12.70 Crore and Profit After Tax (PAT) increased 147.6% to ₹6.24 Crore. The EBITDA margin improved to 20.72% of total income from 12.99%, and the PAT margin to 10.18% from 3.88%. For H1 FY27, total revenue grew 4.0% to ₹153.28 Crore and PAT grew 61.9% to ₹10.70 Crore.
Q2 FY27 Consolidated Financial Results
In Q2 FY27, consolidated financial results showed a significant improvement in profitability. Despite a 5.5% year-on-year decline in revenue, EBITDA increased 50.7% to ₹12.70 Crore and Profit After Tax (PAT) rose 147.6% to ₹6.24 Crore. Total expenses declined 14.2% to ₹52.93 Crore from ₹61.71 Crore in the corresponding quarter last year.
H1 FY27 Consolidated Financial Results
For H1 FY27, revenue from operations grew 4.0% to ₹153.25 Crore, EBITDA increased 30.2% to ₹24.41 Crore and PAT rose 61.9% to ₹10.70 Crore, reflecting improved profitability over the half year. Looking ahead, Kotyark Industries Limited is targeting revenue CAGR of 25 – 30% over the next three years, with an EBITDA margin aspiration of 18 -22%. Growth is expected to be supported by higher biodiesel volumes, improved plant utilisation, operating efficiencies, integrated sourcing advantages and a greater contribution from value added products.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Kotyark Industries Limited
Kotyark Industries Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.
Kotyark falls 8.7% over three months and has not found a floor yet. Thin margins at 6.1% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue consistency is the one bright spot — zero dips in five years shows operational resilience. The stock holds at 50% of its 52-week range with RSI at 44. In other words, neither side has a clear edge right now. The stock rises -8.7% in three months on 34.1% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Kotyark Industries Limited.
-
Consumer Cyclical3 days agoSky GOLD and Diamonds Limited (NSE: Skygold) Q2 and H1 FY27: Revenue at Rs 4,403.45 Crore, PAT Up 111.9%
-
Consumer Cyclical3 days agoKanpur Plastipack Limited (NSE: Kanprpla) Q2 FY27: Revenue, Ebitda & PAT Surge
-
AWL3 days agoAwl Agri Business Limited (AWL) Delivers Strong Q2 FY27 Growth; Revenue Grows 26% to INR 22,202 Crore with Operating Ebitda Up 11% Yoy
-
DYCL3 days agoDynamic Cables Limited (dycl) Scaling with Strength: Q2 FY27 Results Show Strong Growth
-
Consumer Cyclical3 days agoHuhtamaki India Limited Q3 FY26: Net Sales Surge 23.7%, EBIT Up 18%
-
Auto Parts3 days agoSchaeffler India Limited (NSE: Schaeffler) Q3 FY26: Double-digit Growth Across Domestic and Export Businesses
-
ACUTAAS3 days agoAcutaas Chemicals Limited (acutaas) Q2 & H1 FY27 Results: Revenue Up 42.7% Yoy, PAT Surges 71.4%
-
Industrials3 days agoNavkar Corporation Limited Announces Q2 FY27 Results: Revenue Up 15%, Ebitda Surges 20%